These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7518728)

  • 1. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset.
    Juul A; Pedersen SA; Sørensen S; Winkler K; Jørgensen JO; Christiansen JS; Skakkebaek NE
    Eur J Endocrinol; 1994 Jul; 131(1):41-9. PubMed ID: 7518728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
    Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
    Donahue LR; Beamer WG
    J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature.
    Imamoğlu S; Bereket A; Turan S; Taga Y; Haklar G
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):69-74. PubMed ID: 15679071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.
    Vandeweghe M; Taelman P; Kaufman JM
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):409-15. PubMed ID: 8287567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency.
    Wollmann HA; Schönau E; Blum WF; Meyer F; Kruse K; Ranke MB
    Horm Res; 1995; 43(6):249-56. PubMed ID: 7541769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
    Shalet SM; Shavrikova E; Cromer M; Child CJ; Keller E; Zapletalová J; Moshang T; Blum WF; Chipman JJ; Quigley CA; Attanasio AF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
    Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
    Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between alkaline phosphatase and bone alkaline phosphatase activity and the growth hormone/insulin-like growth factor-1 axis and vitamin D status in children with growth hormone deficiency.
    Witkowska-Sędek E; Stelmaszczyk-Emmel A; Majcher A; Demkow U; Pyrżak B
    Acta Biochim Pol; 2018; 65(2):269-275. PubMed ID: 29649340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.